357
Views
3
CrossRef citations to date
0
Altmetric
Eco/Toxicology

Protective effects of vitamin C and curcumin against acrylamide toxicity in embryonic fibroblast cells

ORCID Icon
Pages 389-403 | Received 14 May 2019, Accepted 30 Dec 2019, Published online: 13 Jan 2020
 

Abstract

Acrylamide is a highly soluble and widely produced industrial chemical that has been shown to pose numerous health hazards. This study aimed to assess the effects of acrylamide on the cytotoxicity and oxidative damage in embryonic fibroblast cells (BALB/c 3T3) and to measure protective roles of the natural antioxidants vitamin C and curcumin. Embryonic fibroblast cells were exposed to acrylamide at concentrations of 1, 10, 100, and 1000 μmol/L and vitamin C (50 μmol/L) or curcumin (2.5 μmol/L) for 24 h. Cell viability, cytotoxicity, the activities of antioxidant enzymes superoxide dismutase, glutathione-S-transferase, glutathione peroxidase and catalase, and the markers of oxidative lipid peroxidation, hydroxyl radical, hydrogen peroxide and glutathione were measured. Co-treatment of the acrylamide-exposed fibroblast cells with vitamin C or curcumin attenuated the cytotoxicity and formation of reactive oxygen species and decreased the antioxidant enzyme activity. Thus, it was concluded that vitamin C and curcumin may play a protective role against acrylamide toxicity; the treatment with 50 μmol/L vitamin C was found to be more effective than the treatment with 2.5 μmol/L curcumin.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.